{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T08:52:52Z","timestamp":1770972772227,"version":"3.50.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"13","license":[{"start":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T00:00:00Z","timestamp":1757376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T00:00:00Z","timestamp":1757376000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1245\/s10434-025-18203-x","type":"journal-article","created":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T13:19:10Z","timestamp":1757423950000},"page":"9723-9730","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Recurrence Incidence and Optimal Surveillance After Complete Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in Mucinous Appendix Cancer"],"prefix":"10.1245","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3921-7210","authenticated-orcid":false,"given":"V.","family":"Kovalik","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4132-9489","authenticated-orcid":false,"given":"A.","family":"Sardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3376-3827","authenticated-orcid":false,"given":"M. C.","family":"King","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-9778-4208","authenticated-orcid":false,"given":"S.","family":"Iugai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5065-1416","authenticated-orcid":false,"given":"L. F.","family":"Falla-Zuniga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-8341-8558","authenticated-orcid":false,"given":"K.","family":"Uzhegova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6337-5278","authenticated-orcid":false,"given":"C.","family":"Nieroda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6151-5660","authenticated-orcid":false,"given":"V.","family":"Gushchin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,9,9]]},"reference":[{"issue":"1","key":"18203_CR1","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1097\/PAS.0000000000000535","volume":"40","author":"NJ Carr","year":"2016","unstructured":"Carr NJ, Cecil TD, Mohamed F, et al. A consensus for classification and pathologic reporting of pseudomyxoma peritonei and associated appendiceal neoplasia: the results of the peritoneal surface oncology group international (PSOGI) modified delphi process. Am J Surg Pathol. 2016;40(1):14\u201326. https:\/\/doi.org\/10.1097\/PAS.0000000000000535.","journal-title":"Am J Surg Pathol."},{"issue":"12","key":"18203_CR2","doi-asserted-by":"publisher","first-page":"7848","DOI":"10.1245\/s10434-023-14145-4","volume":"30","author":"A Nikiforchin","year":"2023","unstructured":"Nikiforchin A, Sardi A, King MC, et al. Patterns of recurrence in appendix cancer after complete cytoreduction and hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol. 2023;30(12):7848\u201357. https:\/\/doi.org\/10.1245\/s10434-023-14145-4.","journal-title":"Ann Surg Oncol."},{"issue":"2","key":"18203_CR3","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1245\/s10434-018-6860-4","volume":"26","author":"Y Feferman","year":"2019","unstructured":"Feferman Y, Solomon D, Bhagwandin S, et al. Sites of recurrence after complete cytoreduction and hyperthermic intraperitoneal chemotherapy for patients with peritoneal carcinomatosis from colorectal and appendiceal adenocarcinoma: a tertiary center experience. Ann Surg Oncol. 2019;26(2):482\u20139. https:\/\/doi.org\/10.1245\/s10434-018-6860-4.","journal-title":"Ann Surg Oncol."},{"issue":"1","key":"18203_CR4","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1245\/s10434-023-14422-2","volume":"31","author":"N Bhutiani","year":"2024","unstructured":"Bhutiani N, Grotz TE, Concors SJ, et al. Repeat cytoreduction and hyperthermic intraperitoneal chemotherapy for recurrent mucinous appendiceal adenocarcinoma: a viable treatment strategy with demonstrable benefit. Ann Surg Oncol. 2024;31(1):614\u201321. https:\/\/doi.org\/10.1245\/s10434-023-14422-2.","journal-title":"Ann Surg Oncol."},{"issue":"6","key":"18203_CR5","doi-asserted-by":"publisher","first-page":"3390","DOI":"10.1245\/s10434-021-11233-1","volume":"29","author":"F Lopez-Ramirez","year":"2022","unstructured":"Lopez-Ramirez F, Gushchin V, Sittig M, et al. Iterative cytoreduction and hyperthermic intraperitoneal chemotherapy for recurrent mucinous adenocarcinoma of the appendix. Ann Surg Oncol. 2022;29(6):3390\u2013401. https:\/\/doi.org\/10.1245\/s10434-021-11233-1.","journal-title":"Ann Surg Oncol."},{"issue":"5","key":"18203_CR6","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1245\/s10434-019-08141-w","volume":"27","author":"E Bekhor","year":"2020","unstructured":"Bekhor E, Carr J, Hofstedt M, et al. The safety of iterative cytoreductive surgery and HIPEC for peritoneal carcinomatosis: a high volume center prospectively maintained database analysis. Ann Surg Oncol. 2020;27(5):1448\u201355. https:\/\/doi.org\/10.1245\/s10434-019-08141-w.","journal-title":"Ann Surg Oncol."},{"issue":"5","key":"18203_CR7","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1245\/s10434-019-07218-w","volume":"26","author":"HA Choudry","year":"2019","unstructured":"Choudry HA, Bednar F, Shuai Y, et al. Repeat cytoreductive surgery-hyperthermic intraperitoneal chemoperfusion is feasible and offers survival benefit in select patients with peritoneal metastases. Ann Surg Oncol. 2019;26(5):1445\u201353. https:\/\/doi.org\/10.1245\/s10434-019-07218-w.","journal-title":"Ann Surg Oncol."},{"issue":"6","key":"18203_CR8","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1002\/jso.24703","volume":"116","author":"IT Konstantinidis","year":"2017","unstructured":"Konstantinidis IT, Levine EA, Chouliaras K, Russell G, Shen P, Votanopoulos KI. Interval between cytoreductions as a marker of tumor biology in selecting patients for repeat cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. J Surg Oncol. 2017;116(6):741\u20135. https:\/\/doi.org\/10.1002\/jso.24703.","journal-title":"J Surg Oncol."},{"key":"18203_CR9","unstructured":"National Comprehensive Cancer Network. Colon Cancer (Version 5.2024 \u2014 August 22, 2024)"},{"issue":"1","key":"18203_CR10","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1245\/s10434-019-07526-1","volume":"27","author":"AC Gamboa","year":"2020","unstructured":"Gamboa AC, Zaidi MY, Lee RM, et al. Optimal surveillance frequency after CRS\/HIPEC for appendiceal and colorectal neoplasms: a multi-institutional analysis of the US HIPEC collaborative. Ann Surg Oncol. 2020;27(1):134\u201346. https:\/\/doi.org\/10.1245\/s10434-019-07526-1.","journal-title":"Ann Surg Oncol."},{"issue":"3","key":"18203_CR11","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1001\/jama.2013.285718","volume":"311","author":"JN Primrose","year":"2014","unstructured":"Primrose JN, Perera R, Gray A, et al. Effect of 3 to 5 years of scheduled CEA and CT follow-up to detect recurrence of colorectal cancer: the FACS randomized clinical trial. JAMA. 2014;311(3):263. https:\/\/doi.org\/10.1001\/jama.2013.285718.","journal-title":"JAMA."},{"issue":"9","key":"18203_CR12","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1002\/cncr.34656","volume":"129","author":"HB Neuman","year":"2023","unstructured":"Neuman HB, Schumacher JR, Edge SB, et al. The influence of anatomic stage and receptor status on first recurrence for breast cancer within 5 years (AFT-01). Cancer. 2023;129(9):1351\u201360. https:\/\/doi.org\/10.1002\/cncr.34656.","journal-title":"Cancer."},{"key":"18203_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2021.105365","volume":"119","author":"F De Felice","year":"2021","unstructured":"De Felice F, Lei M, Oakley R, et al. Risk stratified follow up for head and neck cancer patients \u2013 an evidence based proposal. Oral Oncol. 2021;119:105365. https:\/\/doi.org\/10.1016\/j.oraloncology.2021.105365.","journal-title":"Oral Oncol."},{"issue":"5","key":"18203_CR14","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1093\/neuonc\/noab053","volume":"23","author":"MJ Lim-Fat","year":"2021","unstructured":"Lim-Fat MJ, Maralani PJ. Is there an optimal MRI surveillance schedule for patients with high-grade glioma after standard-of-care-therapy? Neuro-Oncol. 2021;23(5):711\u20132. https:\/\/doi.org\/10.1093\/neuonc\/noab053.","journal-title":"Neuro-Oncol."},{"issue":"1","key":"18203_CR15","doi-asserted-by":"publisher","first-page":"MMT12","DOI":"10.2217\/mmt-2019-0003","volume":"6","author":"M Freeman","year":"2019","unstructured":"Freeman M, Laks S. Surveillance imaging for metastasis in high-risk melanoma: importance in individualized patient care and survivorship. Melanoma Manag. 2019;6(1):MMT12. https:\/\/doi.org\/10.2217\/mmt-2019-0003.","journal-title":"Melanoma Manag."},{"issue":"3","key":"18203_CR16","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1097\/DCR.0000000000001003","volume":"61","author":"BK Paul","year":"2018","unstructured":"Paul BK, Ihemelandu C, Sugarbaker PH. Prior surgical score: an analysis of the prognostic significance of an initial nondefinitive surgical intervention in patients with peritoneal carcinomatosis of a colorectal origin undergoing cytoreductive surgery and perioperative intraperitoneal chemotherapy. Dis Colon Rectum. 2018;61(3):347\u201354. https:\/\/doi.org\/10.1097\/DCR.0000000000001003.","journal-title":"Dis Colon Rectum."},{"key":"18203_CR17","doi-asserted-by":"publisher","unstructured":"Jacquet P, Sugarbaker PH. Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis. In: Sugarbaker PH, ed. Peritoneal Carcinomatosis: Principles of Management. Vol 82. Cancer Treatment and Research. Springer US; 1996:359-74. https:\/\/doi.org\/10.1007\/978-1-4613-1247-5_23","DOI":"10.1007\/978-1-4613-1247-5_23"},{"issue":"7","key":"18203_CR18","doi-asserted-by":"publisher","first-page":"S15","DOI":"10.1007\/s002800051093","volume":"43","author":"PH Sugarbaker","year":"1999","unstructured":"Sugarbaker PH. Successful management of microscopic residual disease in large bowel cancer. Cancer Chemother Pharmacol. 1999;43(7):S15-25. https:\/\/doi.org\/10.1007\/s002800051093.","journal-title":"Cancer Chemother Pharmacol."},{"issue":"4","key":"18203_CR19","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1002\/jso.26371","volume":"123","author":"A Nikiforchin","year":"2021","unstructured":"Nikiforchin A, Gushchin V, King MC, et al. Surgical and oncological outcomes after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy at a nonacademic center: 25-year experience. J Surg Oncol. 2021;123(4):1030\u201344. https:\/\/doi.org\/10.1002\/jso.26371.","journal-title":"J Surg Oncol."},{"issue":"1","key":"18203_CR20","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1002\/sim.5915","volume":"33","author":"G Han","year":"2014","unstructured":"Han G, Schell MJ, Kim J. Improved survival modeling in cancer research using a reduced piecewise exponential approach. Stat Med. 2014;33(1):59\u201373. https:\/\/doi.org\/10.1002\/sim.5915.","journal-title":"Stat Med."},{"issue":"1","key":"18203_CR21","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1001\/jamaoncol.2023.5098","volume":"10","author":"J Nors","year":"2024","unstructured":"Nors J, Iversen LH, Erichsen R, Gotschalck KA, Andersen CL. Incidence of recurrence and time to recurrence in stage I to III colorectal cancer: a nationwide Danish cohort study. JAMA Oncol. 2024;10(1):54. https:\/\/doi.org\/10.1001\/jamaoncol.2023.5098.","journal-title":"JAMA Oncol."},{"issue":"11","key":"18203_CR22","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1001\/jamaoto.2022.2561","volume":"148","author":"HI Lee","year":"2022","unstructured":"Lee HI, Lee J, Lee JH, et al. Evaluation of optimal assessment schedules for surveillance after definitive locoregional treatment of locally advanced head and neck cancer: a retrospective cohort study with parametric modeling of event-free survival. JAMA Otolaryngol Neck Surg. 2022;148(11):1059. https:\/\/doi.org\/10.1001\/jamaoto.2022.2561.","journal-title":"JAMA Otolaryngol Neck Surg."},{"issue":"5","key":"18203_CR23","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1093\/neuonc\/noaa250","volume":"23","author":"SY Ji","year":"2021","unstructured":"Ji SY, Lee J, Lee JH, et al. Radiological assessment schedule for high-grade glioma patients during the surveillance period using parametric modeling. Neuro-Oncol. 2021;23(5):837\u201347. https:\/\/doi.org\/10.1093\/neuonc\/noaa250.","journal-title":"Neuro-Oncol."},{"issue":"S3","key":"18203_CR24","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1245\/s10434-018-6341-9","volume":"25","author":"M Guaglio","year":"2018","unstructured":"Guaglio M, Sinukumar S, Kusamura S, et al. Correction to: clinical surveillance after macroscopically complete surgery for low-grade appendiceal mucinous neoplasms (LAMN) with or without limited peritoneal spread: long-term results in a prospective series. Ann Surg Oncol. 2018;25(S3):987. https:\/\/doi.org\/10.1245\/s10434-018-6341-9.","journal-title":"Ann Surg Oncol."},{"issue":"4","key":"18203_CR25","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1002\/jso.25642","volume":"120","author":"LS Kyang","year":"2019","unstructured":"Kyang LS, Alzahrani NA, Valle SJ, et al. Long-term survival outcomes of cytoreductive surgery and perioperative intraperitoneal chemotherapy: single-institutional experience with 1225 cases. J Surg Oncol. 2019;120(4):794\u2013802. https:\/\/doi.org\/10.1002\/jso.25642.","journal-title":"J Surg Oncol."},{"issue":"1","key":"18203_CR26","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s11605-019-04336-4","volume":"24","author":"NC Levinsky","year":"2020","unstructured":"Levinsky NC, Morris MC, Wima K, et al. Should we be doing cytoreductive surgery with HIPEC for signet ring cell appendiceal adenocarcinoma? A study from the US HIPEC collaborative. J Gastrointest Surg. 2020;24(1):155\u201364. https:\/\/doi.org\/10.1007\/s11605-019-04336-4.","journal-title":"J Gastrointest Surg."},{"issue":"2","key":"18203_CR27","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1245\/s10434-018-7007-3","volume":"26","author":"C Munoz-Zuluaga","year":"2019","unstructured":"Munoz-Zuluaga C, Sardi A, King MC, et al. Outcomes in peritoneal dissemination from signet ring cell carcinoma of the appendix treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol. 2019;26(2):473\u201381. https:\/\/doi.org\/10.1245\/s10434-018-7007-3.","journal-title":"Ann Surg Oncol."},{"issue":"3","key":"18203_CR28","doi-asserted-by":"publisher","first-page":"1840","DOI":"10.1245\/s10434-022-12753-0","volume":"30","author":"EW Beal","year":"2023","unstructured":"Beal EW, Srinivas S, Shen C, et al. Conditional survival following cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for peritoneal surface malignancies: an analysis from the US HIPEC Collaborative. Ann Surg Oncol. 2023;30(3):1840\u20139. https:\/\/doi.org\/10.1245\/s10434-022-12753-0.","journal-title":"Ann Surg Oncol."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-18203-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-025-18203-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-18203-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T14:18:43Z","timestamp":1762352323000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-025-18203-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,9]]},"references-count":28,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["18203"],"URL":"https:\/\/doi.org\/10.1245\/s10434-025-18203-x","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,9]]},"assertion":[{"value":"29 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This cohort study was conducted using an institutional review board approved prospectively maintained database.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}